(FLRN) SPDR Bloomberg Investment - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78468R2004
FLRN: Floating, Rate, Notes, Bonds, Investment, Grade
The SPDR Bloomberg Investment Grade Floating Rate ETF (FLRN) is designed to track the performance of U.S. dollar-denominated, investment-grade floating-rate notes. By investing at least 80% of its assets in securities that comprise the underlying index or have similar economic characteristics, the fund provides exposure to a diversified portfolio of floating-rate debt instruments.
The ETFs investment strategy is centered around capturing the benefits of floating-rate notes, which offer a relatively low sensitivity to interest rate changes due to their adjustable coupon rates. This makes FLRN an attractive option for investors seeking to mitigate the impact of rising interest rates on their fixed-income investments. With a large asset base, the fund is well-positioned to provide liquidity and diversification to investors.
From a technical analysis perspective, FLRN has demonstrated a stable price action, with the current price of $30.73 hovering above its 20-day, 50-day, and 200-day moving averages. The support levels at $30.2 and $30.0 are likely to provide a floor for the price, while the low Average True Range (ATR) of 0.03 indicates a relatively stable trading environment. Given the current market conditions and the funds underlying characteristics, a potential forecast for FLRN could be a continued consolidation around the current price levels, with a potential upside target near the 52-week high of $30.73.
Combining the technical and fundamental analysis, a forecast for FLRN could be made. With the current interest rate environment and the funds focus on floating-rate notes, it is likely that FLRN will continue to attract investors seeking to manage interest rate risk. As the funds AUM stands at $2.74 billion, it is well-established in the market. Assuming a continued stable interest rate environment, a potential price target for FLRN could be $31.00, representing a 1% upside from current levels. However, a rise in interest rate volatility could lead to a reversion to the mean, potentially testing the support levels at $30.2 and $30.0.
Additional Sources for FLRN ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
FLRN ETF Overview
Market Cap in USD | 2,718m |
Category | Ultrashort Bond |
TER | 0.15% |
IPO / Inception | 2011-11-30 |
FLRN ETF Ratings
Growth Rating | 72.7 |
Fundamental | - |
Dividend Rating | 74.7 |
Rel. Strength | 9.17 |
Analysts | - |
Fair Price Momentum | 31.62 USD |
Fair Price DCF | - |
FLRN Dividends
Dividend Yield 12m | 5.39% |
Yield on Cost 5y | 6.32% |
Annual Growth 5y | 36.21% |
Payout Consistency | 79.0% |
Payout Ratio | % |
FLRN Growth Ratios
Growth Correlation 3m | 94.7% |
Growth Correlation 12m | 99% |
Growth Correlation 5y | 93.2% |
CAGR 5y | 3.52% |
CAGR/Max DD 5y | 1.63 |
Sharpe Ratio 12m | 2.08 |
Alpha | 0.63 |
Beta | 0.064 |
Volatility | 0.96% |
Current Volume | 549.4k |
Average Volume 20d | 586.7k |
As of June 25, 2025, the stock is trading at USD 30.79 with a total of 549,395 shares traded.
Over the past week, the price has changed by +0.13%, over one month by +0.42%, over three months by +1.14% and over the past year by +5.40%.
Yes. Based on ValueRay´s Analyses, SPDR Bloomberg Investment (NYSE ARCA:FLRN) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 72.65 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FLRN is around 31.62 USD . This means that FLRN is currently overvalued and has a potential downside of 2.7%.
SPDR Bloomberg Investment has no consensus analysts rating.
According to our own proprietary Forecast Model, FLRN SPDR Bloomberg Investment will be worth about 34.2 in June 2026. The stock is currently trading at 30.79. This means that the stock has a potential upside of +10.91%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 34.2 | 10.9% |